Mirae Asset Global Investments
BMRN icon

Mirae Asset Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mirae Asset Global Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Sell
9,079
-2,403
-21% -$132K ﹤0.01% 973
2026
Q1 		$649K Buy
11,482
+801
+7% +$46.7K ﹤0.01% 896
2025
Q4 		$635K Buy
10,681
+1,581
+17% +$86.1K ﹤0.01% 965
2025
Q3 		$493K Buy
9,100
+305
+3% +$17.4K ﹤0.01% 986
2025
Q2 		$483K Buy
8,795
+1,127
+15% +$66.4K ﹤0.01% 948
2025
Q1 		$548K Buy
7,668
+78
+1% +$5.25K ﹤0.01% 910
2024
Q4 		$507K Sell
7,590
-814
-10% -$54.5K ﹤0.01% 945
2024
Q3 		$593K Buy
8,404
+1,167
+16% +$97.5K ﹤0.01% 934
2024
Q2 		$604K Sell
7,237
-100,844
-93% -$8.4M ﹤0.01% 887
2024
Q1 		$9.83M Buy
108,081
+56,784
+111% +$5.08M 0.02% 646
2023
Q4 		$4.95M Sell
51,297
-50,979
-50% -$4.51M 0.01% 895
2023
Q3 		$9.05M Buy
102,276
+1,359
+1% +$121K 0.02% 652
2023
Q2 		$8.75M Sell
100,917
-100,848
-50% -$9.49M 0.02% 707
2023
Q1 		$19.6M Buy
201,765
+98,818
+96% +$10.2M 0.05% 407
2022
Q4 		$10.7M Sell
102,947
-17,990
-15% -$1.69M 0.03% 580
2022
Q3 		$10.3M Buy
120,937
+12,409
+11% +$1.1M 0.03% 565
2022
Q2 		$8.99M Sell
108,528
-30,542
-22% -$2.43M 0.02% 636
2022
Q1 		$10.7M Sell
139,070
-24,177
-15% -$2.02M 0.02% 650
2021
Q4 		$14.4M Buy
163,247
+12,550
+8% +$1.04M 0.03% 566
2021
Q3 		$11.6M Buy
150,697
+29,653
+24% +$2.34M 0.03% 585
2021
Q2 		$10.1M Buy
121,044
+27,156
+29% +$2.15M 0.03% 626
2021
Q1 		$7.09M Buy
93,888
+35,280
+60% +$2.88M 0.02% 649
2020
Q4 		$5.14M Sell
58,608
-16,459
-22% -$1.3M 0.02% 648
2020
Q3 		$5.71M Buy
75,067
+15,502
+26% +$1.57M 0.03% 522
2020
Q2 		$7.35M Buy
59,565
+10,984
+23% +$1.09M 0.04% 401
2020
Q1 		$4.11M Buy
48,581
+6,948
+17% +$599K 0.03% 479
2019
Q4 		$3.52M Buy
41,633
+7,913
+23% +$598K 0.02% 593
2019
Q3 		$2.27M Buy
33,720
+7,582
+29% +$584K 0.02% 674
2019
Q2 		$2.23M Buy
26,138
+4,216
+19% +$361K 0.02% 668
2019
Q1 		$1.94M Buy
21,922
+2,098
+11% +$194K 0.01% 654
2018
Q4 		$1.69M Buy
19,824
+2,753
+16% +$262K 0.02% 645
2018
Q3 		$1.66M Buy
17,071
+3,431
+25% +$342K 0.01% 698
2018
Q2 		$1.27M Buy
13,640
+1,918
+16% +$168K 0.02% 467
2018
Q1 		$951K Buy
11,722
+341
+3% +$29.3K 0.01% 504
2017
Q4 		$1.01M Buy
11,381
+1,030
+10% +$89.6K 0.01% 474
2017
Q3 		$963K Buy
10,351
+2,300
+29% +$203K 0.02% 430
2017
Q2 		$727K Buy
8,051
+1,567
+24% +$143K 0.01% 432
2017
Q1 		$569K Buy
6,484
+3,642
+128% +$324K 0.01% 443
2016
Q4 		$235K Sell
2,842
-1,884
-40% -$162K 0.01% 484
2016
Q3 		$437K Sell
4,726
-1,618
-26% -$152K 0.01% 463
2016
Q2 		$494K Buy
6,344
+217
+4% +$18.4K 0.01% 403
2016
Q1 		$505K Buy
6,127
+282
+5% +$22.9K 0.01% 388
2015
Q4 		$612K Buy
5,845
+1,589
+37% +$166K 0.02% 359
2015
Q3 		$448K Buy
4,256
+168
+4% +$22.4K 0.02% 352
2015
Q2 		$559K Buy
4,088
+284
+7% +$35.2K 0.02% 364
2015
Q1 		$474K Buy
3,804
+312
+9% +$33.1K 0.02% 374
2014
Q4 		$316K Buy
3,492
+2
+0.1% +$166 0.01% 387
2014
Q3 		$252K Buy
+3,490
New +$229K 0.01% 426
2013
Q3 		– Sell
-10,362
Closed -$578K – 407
2013
Q2 		$578K Buy
+10,362
New +$646K 0.03% 326

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Mirae Asset Global Investments's BMRN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 21% in Q2 2026, selling an estimated $132K and leaving 9,079 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Mirae Asset Global Investments first reported a position in BMRN in Q2 2013 and has held it in 49 quarters since. The position peaked at $19.6M in Q1 2023. 265 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Mirae Asset Global Investments held 9,079 shares of BioMarin Pharmaceuticals worth $520K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,403 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $132K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #973 holding.
  • Mirae Asset Global Investments first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Mirae Asset Global Investments's BioMarin Pharmaceuticals position peaked at $19.6M in Q1 2023.
  • 265 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.